FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4364379653> ?p ?o ?g. }

• W4364379653 endingPage "e15444" @default.
• W4364379653 startingPage "e15444" @default.
• W4364379653 abstract "Blood clotting has become one of the most dangerous side effects associated with Corona virus, as well as the high level of cholesterol and triglycerides in the blood. Therefore, it has become necessary to use medicinal plants that are biologically safe and containing anti-clotting compound. Feijoa sellowiana represents a prolific source diverse compounds that may have thrombolytic activity. Therefore, the main research point is the production and scaling up of a target contents that have anticoagulants by using biotechnological techniques; calli production, and bioreactors and assessed their activity through in-vivo study. Murashige and Skoog (MS) medium enriched with varying concentrations of benzyl adenine (BA) and naphthalene acetic acid (NAA) was used to cultivate calli and cell suspension cultures from F. sellowiana seeds. Bioreactors were employed to boost active constituent's production. Moreover, the bioreactor physical factors such as effect of controlled or uncontrolled pH medium were investigated. The leaves of the main plant were extracted by ethanol 70% and polar and non-polar extracts were also prepared. The ethanol extract of calli and cells resulting from bioreactors were also prepared. All prepared extracts were subjected to chemical analysis by HPLC, in-vitro antioxidant assays, in-vivo anticoagulant activity and histopathological examination. Calli and cell suspension cultures were produced by using MS medium fortified with 1 mg/L BA+ 0.1 mg/L NAA. It was found that culturing of cell cultures in a bioreactor with uncontrolled pH and aeration at the value of 0.5 L/min gave the maximum and economical fresh and dry weights of the plants. After evaluation of all extracts; it was found that the calli ethanol extract for each plant was the highest value of total phenolic and total flavonoid contents either quantitatively or qualitatively. All extracts of Feijoa had antioxidant activity. The IC50 of the DPPH of Feijoa calli extract was 13.45 μg/mL, it was also confirmed by FRAP and ABTs values. Feijoa calli extract decreased platelet aggregation by suppression of thrombin, extended aPTT, PT, bleeding and clotting times. It was safer than warfarin medication. From these findings the authors can conclude that Feijoa had highly anticoagulant activity and the calli production achieved the goal of the enhancement of the phenolic constituent and thus their activity." @default.
• W4364379653 created "2023-04-12" @default.
• W4364379653 creator A5038366070 @default.
• W4364379653 creator A5038615527 @default.
• W4364379653 creator A5064978300 @default.
• W4364379653 creator A5078124874 @default.
• W4364379653 date "2023-04-01" @default.
• W4364379653 modified "2023-09-30" @default.
• W4364379653 title "Anticoagulant effect of Feijoa sellowiana extracts generated by different biotechnological techniques" @default.
• W4364379653 cites W173411000 @default.
• W4364379653 cites W1973228336 @default.
• W4364379653 cites W1980353574 @default.
• W4364379653 cites W1990650349 @default.
• W4364379653 cites W1996133279 @default.
• W4364379653 cites W1998936301 @default.
• W4364379653 cites W2000180273 @default.
• W4364379653 cites W2012402976 @default.
• W4364379653 cites W2019177180 @default.
• W4364379653 cites W2024556021 @default.
• W4364379653 cites W2028697582 @default.
• W4364379653 cites W2043394820 @default.
• W4364379653 cites W2050908002 @default.
• W4364379653 cites W2055624808 @default.
• W4364379653 cites W2056758965 @default.
• W4364379653 cites W2059862485 @default.
• W4364379653 cites W2066812140 @default.
• W4364379653 cites W2074924882 @default.
• W4364379653 cites W2083409769 @default.
• W4364379653 cites W2088667362 @default.
• W4364379653 cites W2092164073 @default.
• W4364379653 cites W2129257067 @default.
• W4364379653 cites W2146346788 @default.
• W4364379653 cites W2165292984 @default.
• W4364379653 cites W2209568904 @default.
• W4364379653 cites W2396863739 @default.
• W4364379653 cites W2413177399 @default.
• W4364379653 cites W2781528168 @default.
• W4364379653 cites W2807955065 @default.
• W4364379653 cites W2891388060 @default.
• W4364379653 cites W2971851032 @default.
• W4364379653 cites W2985168897 @default.
• W4364379653 cites W3008171271 @default.
• W4364379653 cites W3104406108 @default.
• W4364379653 cites W3163981165 @default.
• W4364379653 cites W3197233575 @default.
• W4364379653 cites W324208523 @default.
• W4364379653 cites W4210436672 @default.
• W4364379653 cites W4210719104 @default.
• W4364379653 cites W4243030520 @default.
• W4364379653 cites W4281616003 @default.
• W4364379653 doi "https://doi.org/10.1016/j.heliyon.2023.e15444" @default.
• W4364379653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37151701" @default.
• W4364379653 hasPublicationYear "2023" @default.
• W4364379653 type Work @default.
• W4364379653 citedByCount "0" @default.
• W4364379653 crossrefType "journal-article" @default.
• W4364379653 hasAuthorship W4364379653A5038366070 @default.
• W4364379653 hasAuthorship W4364379653A5038615527 @default.
• W4364379653 hasAuthorship W4364379653A5064978300 @default.
• W4364379653 hasAuthorship W4364379653A5078124874 @default.
• W4364379653 hasBestOaLocation W43643796531 @default.
• W4364379653 hasConcept C168170006 @default.
• W4364379653 hasConcept C178790620 @default.
• W4364379653 hasConcept C185592680 @default.
• W4364379653 hasConcept C200806820 @default.
• W4364379653 hasConcept C202751555 @default.
• W4364379653 hasConcept C31903555 @default.
• W4364379653 hasConcept C43617362 @default.
• W4364379653 hasConcept C55493867 @default.
• W4364379653 hasConcept C90703135 @default.
• W4364379653 hasConceptScore W4364379653C168170006 @default.
• W4364379653 hasConceptScore W4364379653C178790620 @default.
• W4364379653 hasConceptScore W4364379653C185592680 @default.
• W4364379653 hasConceptScore W4364379653C200806820 @default.
• W4364379653 hasConceptScore W4364379653C202751555 @default.
• W4364379653 hasConceptScore W4364379653C31903555 @default.
• W4364379653 hasConceptScore W4364379653C43617362 @default.
• W4364379653 hasConceptScore W4364379653C55493867 @default.
• W4364379653 hasConceptScore W4364379653C90703135 @default.
• W4364379653 hasIssue "4" @default.
• W4364379653 hasLocation W43643796531 @default.
• W4364379653 hasLocation W43643796532 @default.
• W4364379653 hasLocation W43643796533 @default.
• W4364379653 hasOpenAccess W4364379653 @default.
• W4364379653 hasPrimaryLocation W43643796531 @default.
• W4364379653 hasRelatedWork W1967257303 @default.
• W4364379653 hasRelatedWork W1986762097 @default.
• W4364379653 hasRelatedWork W2322185396 @default.
• W4364379653 hasRelatedWork W2483004841 @default.
• W4364379653 hasRelatedWork W4288813642 @default.
• W4364379653 hasRelatedWork W4289547115 @default.
• W4364379653 hasRelatedWork W4290723114 @default.
• W4364379653 hasRelatedWork W4312207882 @default.
• W4364379653 hasRelatedWork W4315465116 @default.
• W4364379653 hasRelatedWork W4367664774 @default.
• W4364379653 hasVolume "9" @default.
• W4364379653 isParatext "false" @default.
• W4364379653 isRetracted "false" @default.

• next